Red List

EBSEmergent BioSolutions Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · small-cap ($425M)
-42.8%
from rolling 252-day high of $14.06 set 2026-01-07 · 184d ago
Current
$8.05
Decline depth
-42.8%
Decline σ
2.5σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since tracking began

$EBS has been tracked since 2026-03-01. It was down 36.1% from its 52-week high then — now down -42.8%.

That's 9.6 percentage points deeper than the day it joined.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

EBS qualifies for the Red List on decline depth.

Decline depth
-42.8%
From rolling 252-day high of $14.06, 184d ago. Past the 40% Red List threshold.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 3/5 Watch threshold.
Decline sigma
2.5σ
Drop from local high over the last 10 bars, expressed in units of the stock's typical daily volatility (3.23% per day).

The structural read

What price action says about EBS.

EBS qualifies for the Red List on decline depth — down -42.8% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.

Cross-confirmation: also showing 3/5 bearish time frames.

Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 2D (red), monthly 1 (red).

Earnings on file: 2026-04-30. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $5.62 28.8% of range 52W high $14.06

Sector context · Healthcare

132 other Healthcare tickers are on Broken Stocks.

61 Red List
34 Amber
37 Watch
-36.1% Median decline

Worst in sector: UPB (-77.6%). Least-bad: ENTA (-20.1%). See all Healthcare listings →

Questions about EBS

What people ask.

Why is EBS on Broken Stocks?

EBS qualifies for the Red List on decline depth. It is down -42.8% from its rolling 252-day high of $14.06, set on 2026-01-07 — 184d ago.

Is EBS a falling knife?

Not by the strict technical definition. EBS is down -42.8% from its 52-week high, but that high was set 184d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. EBS is still on the Red List for decline depth, but the freshness component of a falling knife is missing.

Is EBS a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is EBS trading inside its 52-week range?

At $8.05, EBS sits 28.8% of the way from its 52-week low ($5.62) to its 52-week high ($14.06). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has EBS been declining?

The current 42.8% decline accrued over 184d, which annualizes to roughly -84.9% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does EBS compare to its sector?

There are 132 other Healthcare tickers on Broken Stocks: 61 Red, 34 Amber, 37 Watch, with 46 showing recovering structural signals. Median sector decline is -36.1% — EBS's decline is deeper than the sector median.

Does EBS's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-04-30) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.